Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Registry of the BioFreedom™ BA9™ Ultra Drug-Coated Coronary Stent for Patients With ST Elevation Myocardial Infarct (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)

NCT05331547 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05331547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05331547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Registry of the BioFreedom™ BA9™ Ultra Drug-Coated Coronary Stent for Patients With ST Elevation Myocardial Infarct (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Unknown status
Start date
July 21, 2021
Completion date
January 21, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular death, myocardial infarction, revascularization